Plasma-derived therapies allow individuals with chronic and life threatening diseases to lead more productive and healthy lives by replacing the missing or deficient proteins. The patients relying on these therapies require regular injections or infusions throughout their lives.
Since the diseases treated by plasma therapies affect a small percentage of the population, they are often considered as rare. Most of these diseases are genetic and chronic conditions. However, over the years there is a rise in these rare diseases demanding more treatment options.
There have been initiatives to create awareness about the plasma-derived protein therapies and its importance. For instance, CSL Behring and Plasma Protein Therapeutics Association (PPTA's) other global member companies, In 2018, the PPTA launched a video campaign and called it as “How Is Your Day?”.
The objectives of the campaign were to differentiate traditional from the plasma-derived protein therapies and to highlight the value plasma-derived protein therapies provide to individuals with rare and serious conditions. These initiatives are further expected to boost the growth of the plasma-derived protein therapies market.
Higher volume of immunoglobulin usage in developed countries and strong demand for albumin in Asia pacific is expected to drive the growth of the plasma-derived protein therapies market during the forecast period. Increasing focus and growing investment in innovation is anticipated to propel the growth of the plasma-derived protein therapies market.
For Instance, in March 2016, Grifols announced an investment of US$ 360 Mn to expand its capabilities in the production of plasma-derived therapies. The investment will increase the purification and plasma fractionation capacity of several proteins. Thus leading the plasma-derived protein therapies market towards a significant growth.
In addition, rising incidence of life threatening diseases such as multifocal motor neuropathy (MMN), ideopathic thrombocytopenic purpura (ITP) and other infectious diseases including rabies tetanus, hepatitis A&B, and varicella is also expected to drive the growth of the market.
According to WHO estimates that in 2015, around 257 million were living with chronic hepatitis B infection.However, high cost of these therapies may restrict the growth of the plasma-derived protein therapies market. Moreover, stringent regulations and reimbursement scenario may hamper the plasma-derived protein therapies market during the forecast period.
Based on type, the immunoglobulin segment is expected to account for the largest share due to its beneficial application in treating patients with rare diseases. Additionally, Albumin is also expected to lead considerable growth in this segment owing to its demand in developing countries.
In the application segment, the immunological disorders are expected to hold the highest share due to growing awareness about treatment options provided by plasma-derived therapies. Based on end user, the hospital segment is expected to have the largest share due to frequent patient visits for diagnosis and treatment of various infectious and immunological disorders.
Geographically, the Plasma-derived protein therapies market is segmented into seven regions, i.e.; Latin America, South Asia, Oceania, East Asia, Europe, North America and Middle East & Africa.
The North America is expected to account for the largest share in the Plasma-derived protein therapies market due to rising geriatric population who are more susceptible to life threatening diseases. According to the U.S Census Bureau, there were 40.3 million U.S. residents 65 years and older in the 2010 census and more than 54 million on July 1, 2019.
Other factors contributing towards the growth of the regional growth of the market in North America is large patient base and well- developed healthcare infrastructure.Asia Pacific is expected to experience fastest growth in the plasma-derived protein therapies market. Increasing demand for advanced treatment option and rise in per capita expenditure are predicted to drive the growth of the market in this region.
Additionally, the increasing focus in the development of healthcare infrastructure in the developing countries is also anticipated to drive the growth of the plasma-derived protein therapies market in Asia Pacific during the forecast period.
Some of the players identified in the Plasma-derived protein therapies market include:
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Tentatively, the global Plasma-derived protein therapies market has been segmented on the basis of type, route of administration, application and end user.
Based on Type :
Based on Route of Administration :
Based on Application :
Based on End-user :
Our Research Products
The "Full Research Suite" delivers actionable market intel, deep dives on markets or technologies, so clients act faster, cut risk, and unlock growth.
The Leaderboard benchmarks and ranks top vendors, classifying them as Established Leaders, Leading Challengers, or Disruptors & Challengers.
Locates where complements amplify value and substitutes erode it, forecasting net impact by horizon
We deliver granular, decision-grade intel: market sizing, 5-year forecasts, pricing, adoption, usage, revenue, and operational KPIs—plus competitor tracking, regulation, and value chains—across 60 countries broadly.
Spot the shifts before they hit your P&L. We track inflection points, adoption curves, pricing moves, and ecosystem plays to show where demand is heading, why it is changing, and what to do next across high-growth markets and disruptive tech
Real-time reads of user behavior. We track shifting priorities, perceptions of today’s and next-gen services, and provider experience, then pace how fast tech moves from trial to adoption, blending buyer, consumer, and channel inputs with social signals (#WhySwitch, #UX).
Partner with our analyst team to build a custom report designed around your business priorities. From analysing market trends to assessing competitors or crafting bespoke datasets, we tailor insights to your needs.
Supplier Intelligence
Discovery & Profiling
Capacity & Footprint
Performance & Risk
Compliance & Governance
Commercial Readiness
Who Supplies Whom
Scorecards & Shortlists
Playbooks & Docs
Category Intelligence
Definition & Scope
Demand & Use Cases
Cost Drivers
Market Structure
Supply Chain Map
Trade & Policy
Operating Norms
Deliverables
Buyer Intelligence
Account Basics
Spend & Scope
Procurement Model
Vendor Requirements
Terms & Policies
Entry Strategy
Pain Points & Triggers
Outputs
Pricing Analysis
Benchmarks
Trends
Should-Cost
Indexation
Landed Cost
Commercial Terms
Deliverables
Brand Analysis
Positioning & Value Prop
Share & Presence
Customer Evidence
Go-to-Market
Digital & Reputation
Compliance & Trust
KPIs & Gaps
Outputs
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Protein-Coating Line Market Forecast Outlook 2025 to 2035
Protein Labelling Market Size and Share Forecast Outlook 2025 to 2035
Protein Puddings Market Size and Share Forecast Outlook 2025 to 2035
Protein/Antibody Engineering Market Size and Share Forecast Outlook 2025 to 2035
Protein Expression Market Size and Share Forecast Outlook 2025 to 2035
Protein Purification Resin Market Size and Share Forecast Outlook 2025 to 2035
Protein Hydrolysate For Animal Feed Application Market Size and Share Forecast Outlook 2025 to 2035
Protein Crisps Market Outlook - Growth, Demand & Forecast 2025 to 2035
Protein Hydrolysate Market Size and Share Forecast Outlook 2025 to 2035
Protein Supplement Market - Size, Share, and Forecast 2025 to 2035
Protein Powder Market Analysis - Size, Share, and Forecast Outlook 2025 to 2035
Protein Purification and Isolation Market Insights – Size, Share & Forecast 2025 to 2035
Protein Ingredients Market Analysis - Size, Share, and Forecast 2025 to 2035
Protein A Resins Market Trends, Demand & Forecast 2025 to 2035
Proteinase K Market Growth - Trends & Forecast 2025 to 2035
Proteinuria Treatment Market Insights – Demand & Forecast 2025 to 2035
Protein Packaging Market Trends and Forecast 2025 to 2035
Analysis and Growth Projections for Protein Hydrolysate Ingredient Market
Protein Shot Market Analysis by Packaging, Distribution Channel, Product Claims and Regions Through 2035
Protein Diagnostics Market Share, Size and Forecast 2025 to 2035
Plasma-derived Protein Therapies Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA
